Understand the source comparison
Selank Amidate Dosage: Route and Objective Comparison
The following table compares typical Selank Amidate dosage ranges across administration routes and research objectives based on peer-reviewed literature and established research protocols. Acute Anxiolytic Effect 750–1500mcg 1500–3000mcg Single dose 30–60 min
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The following table compares typical Selank Amidate dosage ranges across administration routes and research objectives based on peer-reviewed literature and established research protocols.
- Acute Anxiolytic Effect
- 750–1500mcg
- 1500–3000mcg
- Single dose 30–60 min pre-test
- Acute observation window
- Subcutaneous preferred for consistent peak plasma timing. Intranasal shows higher variability
- Cognitive Enhancement
- 500–1000mcg
- 1000–2000mcg
- Once or twice daily
- 7–21 days
- Twice-daily split dosing maintains stable receptor engagement for neuroplasticity studies
- BDNF Modulation
- 300–750mcg
- Not commonly used
- Once daily
- 7–14 days
- Lower doses sustained over time show superior BDNF upregulation vs high-dose acute administration
- Neuroprotection Models
- 1000–1500mcg
- 14–28 days
- Extended protocols require lower doses to avoid receptor desensitization over multi-week timelines